Sanofi settles 4-year legal battle over Genzyme drug for $315M
November 04, 2019 at 14:28 PM EST
Sanofi S.A. is shelling out $315 million to settle claims it bungled the launch of a multiple sclerosis drug developed by the Cambridge-based subsidiary Genzyme.
